Your browser doesn't support javascript.
loading
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy.
Solomon, Daniel H; Xu, Chang; Collins, Jamie; Kim, Seoyoung C; Losina, Elena; Yau, Vincent; Johansson, Fredrik D.
Afiliação
  • Solomon DH; Division of Rheumatology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA, 02115, USA. dsolomon@bwh.harvard.edu.
  • Xu C; Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, USA. dsolomon@bwh.harvard.edu.
  • Collins J; Division of Rheumatology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA, 02115, USA.
  • Kim SC; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, USA.
  • Losina E; Division of Rheumatology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA, 02115, USA.
  • Yau V; Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, USA.
  • Johansson FD; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, USA.
Arthritis Res Ther ; 23(1): 26, 2021 01 14.
Article em En | MEDLINE | ID: mdl-33446261

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Produtos Biológicos / Antirreumáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Produtos Biológicos / Antirreumáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article